Showing results (11-20 of 316) with videos related to
Sort By:
Pageof 32
International Journal of Environmental Research and Public Health|March 10, 2022
Patients' Engagement in Early Detection of COVID-19 Symptoms: An Observational Study in the Very Early Peak of the Pandemic in Italy in 2020Lorenzo Palamenghi, Fabiola Giudici, Guendalina Graffigna, et al.Critical Reviews in Oncology/Hematology|April 22, 2017
Is still there a place for orteronel in management of prostate cancer? Data from a literature based meta-analysis of randomized trialsGiandomenico Roviello, Chiara Pacifico, Giorgio Chiriacò, et al.Frontiers in Cell and Developmental Biology|April 8, 2021
Role of the IGF-1 Axis in Overcoming Resistance in Breast CancerAnna Ianza, Marianna Sirico, Ottavia Bernocchi, et al.Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|August 14, 2018
Lower urinary tract infections from external beam radiation therapy in prostate cancer: A single institution experienceGiandomenico Roviello, Daniele Generali, Michele Aieta, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 20, 2026
Budget impact analysis of Oncotype DX® multigenic prognostic test in patients with early breast cancer in ItalyOriana Ciani, Carlo Federici, Daniele Generali, et al.Breast Cancer Research and Treatment|October 15, 2010
"Overcoming breast cancer drug resistance with mTOR inhibitors". Could it be a myth or a real possibility in the short-term future?Nadia Margariti, Stephen B Fox, Alberto Bottini, et al.Genes & Cancer|July 7, 2017
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesotheliomaNavid Sobhani, Silvia P Corona, Fabrizio Zanconati, et al.Current Opinion in Oncology|August 23, 2019
Role of dose-dense chemotherapy in high-risk early breast cancerEva Blondeaux, Francesca Poggio, Lucia Del MastroExpert Opinion on Pharmacotherapy|August 3, 2017
Luteininzing hormone releasing hormones analogs in combination with tamoxifen for the adjuvant treatment of premenopausal women with hormone receptor positive breast cancerBenedetta Conte, Francesca Poggio, Lucia Del MastroCells|February 4, 2021
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast CancerNavid Sobhani, Anne Fassl, Giuseppina Mondani, et al.Pageof 32